Why you never really validate your analytical method unless you use the total error approach (part II: Producer and Consumer risks)

PharmaLex
February 26, 2021
12:07 pm

This is a second article in series of articles on the total error approach within the context of analytical method validation. If you missed the first article, I encourage you to read it to get familiar with the total error concept and what we are going to discuss below: https://www.linkedin.com/pulse/why-you-never-really-validate-your-analytical-method-use-de-marchin

Disclaimer:

The contents of this article/presentation are solely the opinion of the author and do not represent the opinions of PharmaLex GmbH or its parent AmerisourceBergen Corporation. PharmaLex and AmerisourceBergen strongly encourage readers/listeners to review available information related to the topics mentioned herein and to rely on their own experience and expertise in making decisions related thereto.